Levercyster: Prognose
Opptil 25 prosent av alle symptomgivende cyster vil kreve kirurgisk inngrep. Behandlingen gjøres så lite skadelig som mulig, men tilbakefallsprosenten ved enklere inngrep er relativt høy, 5-70 prosent, og bare omfattende inngrep som fjerning (reseksjon) og levertransplantasjon er helbredende.
Dette dokumentet er basert på det profesjonelle dokumentet Levercyster . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Hillingsø JG, Kirkegaard P. Levercyster. Ugeskr Læger 2008; 170: 1350-3. PubMed
- Blum SFU, Ittermann T, Kromrey ML, et al. Long-term outcome of incidental cystic liver tumors in the general population. Sci Rep. 2021;11(1):11661. Published 2021 Jun 3. PMID: 34083637 PubMed
- Zhang ZY, Wang ZM, Huang Y. Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management. World J Hepatol. 2020;12(3):72-83. PubMed
- Kabaalioglu A, Ceken K, Alimoglu E et al. Percutaneous imaging-guided treatment of hydatid liver cysts: do long-term results make it a first choice? Eur J Radiol 2006; 59: 65-73. PubMed
- Vogt DP, Henderson JM, Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg 2005; 200: 727-33. PubMed
- Alobaidi M, Shirkhoda A. Malignant cystic and necrotic liver lesions: a pattern approach to discrimination. Curr Probl Diagn Radiol 2004; 33: 254-68. PubMed
- Regev A, Reddy KR. Diagnosis and management of cystic lesions of the liver. UpToDate, last updated Jan 30, 2020. UpToDate
- Krohn PS, Hillingsø JG, Kirkegaard P. Liver transplantation in polycystic liver disease: A relevant treatment modality in adults? Scand J Gastroenterol 2007 Sep 12;1-6 epub ahead of print.
- D'Antiga L, Vallortigara F, Cillo U et al. Features predicting unresectability in hepatoblastoma. Cancer 2007; 110: 1050-8. PubMed